Hikma Pharmaceuticals PLC (HIK.L) LSE

1,533.00

+7(+0.46%)

Updated at December 24 12:35PM

Currency In GBp

Hikma Pharmaceuticals PLC

Address

1 New Burlington Place

London, W1S 2HR

United Kingdom of Great Britain and Northern Ireland

Phone

44 20 7399 2760

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

9500

First IPO Date

November 01, 2005

Key Executives

NameTitlePayYear Born
Riad Ali MishlawiInterim Head of Injectables Business, Chief Executive Officer & Director2.2M1964
Mazen Samih Taleb DarwazehExecutive Vice Chairman & President of MENA1.66M1958
Said Samih Taleb DarwazahExecutive Chairman1.99M1957
Bassam Wael Rushdi KanaanExecutive Vice President of Corporate Development and M&A01965
Guy FeatherstoneAssociate Director of Investor Relations0N/A
Hussein ArkhaghaChief People Officer0N/A
Khalid Walid Hussni Al NabilsiChief Financial Officer01972
Samuel ParkGeneral Counsel0N/A
Helen MiddlemistGroup Company Secretary0N/A
Susan RingdalExecutive Vice President of Strategic Planning & Global Affairs0N/A
Patricia BousfieldChief Information Officer0N/A

Description

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.